UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W
Number of items: 114.

A

Ajzensztejn, D; Hegde, V; Lee, SM; (2006) Tumour lysis syndrome following treatment with standard second-line docetaxel for non-small cell lung cancer. Journal of Clinical Oncology , 24 (15) pp. 2389-2391.

Alonzi, R; Hoskin, P; (2006) Functional imaging in clinical oncology: Magnetic resonance imaging- and computerised tomography-based techniques. CLINICAL ONCOLOGY , 18 (7) pp. 555-570.

Arkenau, HT; (2006) 42nd annual meeting of the American society of clinical oncology, Atlanta, USA, 2006: Adjuvant treatment for colon and rectal cancer. Advances in Gastrointestinal Cancers , 4 (2) pp. 21-22.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) pp. 1602-1609. 10.1158/1535-7163.MCT-06-0018.

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4(+) T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: GUT. (pp. A24 - A24). B M J PUBLISHING GROUP

Ayaru, L; Pereira, SP; Meyer, T; Davidson, BR; Burroughs, AK; Williams, R; Behboudi, S; (2006) Alpha-fetoprotein specific CD4+ T cell responses are unmasked during transarterial embolisation in hepatocellular carcinoma. In: JOURNAL OF HEPATOLOGY. (pp. S11 - S11). ELSEVIER SCIENCE BV

B

Begent, R; (2006) Developing Integrated Informatics Platform for Cancer Research. In: Nagl, S, (ed.) Cancer Bioinformatics: From Therapy Design to Treatment. (pp. 45-55). John Wiley & Sons: Chichester.

Beresford, M; Sanghera, B; Wong, WL; Makris, A; (2006) Imaging of primary breast cancer with F-18-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour. SPRINGER, 233 SPRING STREET, NEW YORK, NY 10013 USA

Beresford, MJ; Burcombe, R; Ah-See, ML; Stott, D; Makris, A; (2006) Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer. CLINICAL ONCOLOGY , 18 (6) pp. 453-458.

Beresford, MJ; Chin, Y; Burcombe, Y; Ah-See, M; Makris, A; (2006) Clinical response assessment after 2 cycles of neoadjuvant chemotherapy for primary breast cancer fails to predict for final clinical response, but does predict for pathological complete response. In: (pp. 44S-44S).

Beresford, MJ; Harris, AL; Ah-See, M; Daley, F; Padhani, AR; Makris, A; (2006) The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer. BRITISH JOURNAL OF CANCER , 95 (12) pp. 1683-1688.

Beresford, MJ; Padhani, AP; Taylor, NJ; Ah-See, M-L; Stirling, JJ; Makris, A; d'Arcy, JA; (2006) Inter- and intraobserver variability in the evaluation of dynamic breast cancer MRI. Journal of Magnetic Resonance Imaging , 24 (6) pp. 1316-1325. 10.1002/jmri.20768.

Beresford, MJ; Wilson, GD; Makris, A; (2006) Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Research , 8 (6)

Bielack, S; Sydes, M; Butterfass-Bahloul, T; Anninga, J; Benninger-Doring, G; Calaminus, G; Dhooge, KC; ... Bernstein, M; + view all (2006) Successful multinational implementation of the European and American Osteosarcoma study EURAMOS-1 within the European Science Foundation's ECT-EUROCORES scheme. In:

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) 642 - 650. 10.1182/blood.2005-07-3041.

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: (pp. 9517-).

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; ... Van Glabbeke, M; + view all (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 524S - 524S). AMER SOC CLINICAL ONCOLOGY

Bourhis, J; Overgaard, J; Audry, H; Ang, KK; Saunders, M; Bernier, J; Horiot, JC; ... Pignon, JP; + view all (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. , 368 (9538) pp. 843-854. 10.1016/S0140-6736(06)69121-6.

Bower, M; Gazzard, B; Mandalia, S; Newsom-Davis, T; Thirlwell, C; Dhillon, T; (2006) A prognostic index for systemic AIDS-related non-hodgkin lymphoma treated in the era of highly active antiretroviral therapy (vol 143, pg 265, 2005). ANN INTERN MED , 144 (8) 620 - 620.

Bridgewater, JA; Floore, A; Warmoes, MO; Veer Van't, L; (2006) Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary? J Clin Oncol , 24 (18_suppl) 20117-.

Buchmueller, K; Bailey, S; Matthews, D; Register, J; Bruce, CD; O'Hare, C; Hartley, J; ... Lee, M; + view all (2006) Molecular recognition of polyamides with DNA: A study on the strong binding of f-ImPyIm to its cognate DNA, ACGCGT. In: (pp. 678-).

Burcombe, R; Wilson, GW; Dowsett, M; Khan, I; Richman, PI; Daley, F; Detre, S; (2006) Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer. Breast Cancer Research , 8 (3) R31-. 10.1186/bcr1508.

C

Carnell, DM; Smith, RE; Daley, FM; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2006) An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance. International Journal of Radiation Oncology Biology Physics , 65 (1) pp. 91-99.

Caroline, R; (2006) I was saved from death by cells harvested from my bones. The Daily Mail

Carrasco, DR; Fenton, T; Sukhdeo, K; Protopopova, M; Enos, M; You, MJ; Di Vizio, D; ... Depinho, RA; + view all (2006) The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell , 9 (5) pp. 379-390. 10.1016/j.ccr.2006.03.028.

Casado, E; Tabernero, J; Melichar, B; Bridgewater, J; Bennouna, J; Delord, J; Sopala, M; ... Johri, A; + view all (2006) Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial. J Clin Oncol , 24 (18_suppl) 3593-.

Cave, J; Davis, B; Lee, SM; Jones, A; (2006) A randomised controlled trial comparing symptom-based and tumour-based teaching for undergraduates medical students. In: (Proceedings) 2006 NCRI Cancer Conference, Birmingham.. (pp. 192-). Annals of Oncology

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) pp. 7411-7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) pp. 1669-1675. 10.1158/1535-7163.MCT-06-0033.

Chang, JC; Makris, A; Hilsenbeck, SJ; Hackett, JR; Jeong, J; Liu, M; Baker, J; ... Shak, S; + view all (2006) Gene expression profiles in formalin-fixed, paraffin-embedded (FFPE) core biopsies predict docetaxel chemosensitivity. In: (pp. 12S-12S).

Channel, 5N; (2006) Cancer drug battle. UNSPECIFIED

Chin, Y; Ravichandran, D; Makris, A; (2006) Exemestane after non-steroidal aromatase inhibitors for post-menopaual women with advanced breast cancer. In: (pp. 167-).

Chin, YS; Bullard, J; Bryant, L; Bownes, P; Ostler, P; Hoskin, PJ; (2006) High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. CLINICAL ONCOLOGY , 18 (7) pp. 474-479.

Chow, E; Hoskin, P; van der Linden, Y; Bottomley, A; Velikova, G; (2006) Quality of life and symptom end points in palliative bone metastases trials. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Chow, E; Hoskin, PJ; Wu, J; Roos, D; van der Linden, Y; Hartsell, W; Vieth, R; ... Pater, J; + view all (2006) A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Cleator, S; Makris, A; Powles, T; (2006) Response to letter "Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy" by Bogaerts et al. (Ann Oncol 2006; 17 : 352-353). UNSPECIFIED

D

Daniels, S; Statham, P; Globe, D; Seddon, B; Whelan, J; (2006) Piloting a novel method of administration – Moving inpatient treatments to ambulatory care. In:

Donovan, E; Coles, C; Westbury, C; Yarnold, J; (2006) Breast. In: External Beam Therapy. Oxford University Press

de Bruin, EC; van de Velde, CJH; van de Pas, S; Nagtegaal, ID; van Krieken, JHJM; Gosens, MJEM; Peltenburg, LTC; ... Marijnen, CAM; + view all (2006) Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res , 12 (21) pp. 6432-6436. 10.1158/1078-0432.CCR-06-0231.

F

Ford, HER; Yap, YS; Miles, DW; Makris, A; Hall, M; Miller, L; Harries, M; ... Johnston, SRD; + view all (2006) A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer. Cancer Chemotherapy and Pharmacology , 58 (6) pp. 809-815.

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; ... Vanhaesebroeck, B; + view all (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature , 441 (7091) 366 - 370. 10.1038/nature04694.

Fox, J; Patkar, V; Thomson, R; (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) pp. 49-54.

Friedmann, Benjamin Jacob; (2006) Modulation of chemotherapy by inhibition of the epidermal growth factor receptor. Doctoral thesis , UCL (University College London). Green open access
file

G

Glynne-Jones, R; Grainger, J; Harrison, M; Ostler, P; Makris, A; (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? BRITISH JOURNAL OF CANCER , 94 (3) pp. 363-371.

Graham, J; Wagner, K; Plummer, R; Wiedenmann, B; Cassidy, J; Kowal, K; McCoy, C; (2006) Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2073-.

Green, AJ; Begent, RHJ; (2006) Generation of voxel phantoms to investigate the effect of statistical noise on image analysis programs. EUR J NUCL MED MOL I , 33 S319 - S319.

Gregory, SG; Barlow, KF; McLay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; ... Prigmore, E; + view all (2006) The DNA sequence and biological annotation of human chromosome 1. Nature , 441 (7091) pp. 315-321. 10.1038/nature04727.

Gupta, N; Saleem, A; Kotz, B; Osman, S; Aboagye, EO; Phillips, R; Vernon, C; ... Price, PM; + view all (2006) Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients. CLINICAL CANCER RESEARCH , 12 (10) pp. 3115-3123.

H

Hamaguchi, A.; (2006) Molecular and cellular pharmacology of novel pyrrolo [2,1-c] [1,4] diazepine-based anticancer agents. Doctoral thesis , University of London. Green open access
file

Harland, SJ; Daugaard, G; Horwich, A; Mead, GM; Fossa, SD; Sokal, M; Morgenstern, D; ... National, CRITCCSG; + view all (2006) The familial influence on bilateral testicular germ cell cancer: Medical Research Council study TER2. In: (pp. 239S, 4590-).

Ho, E; Vassileva, V; Lim-Soo, P; Allen, C; Piquette-Miller, M; (2006) Impact of localized, sustained delivery of paclitaxel on the in vitro and in vivo regulation of P-glycoprotein. In: (Proceedings) 107th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics. (pp. P11-P11). MOSBY, INC

Hopper, C.; (2006) Photodynamic therapy for the treatment of oral cancer. Doctoral thesis , University of London. Green open access
file

Hughes, R; Glynne-Jones, R; Grainger, J; Richman, P; Makris, A; Harrison, M; Ashford, R; ... Novell, JR; + view all (2006) Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? International Journal of Colorectal Disease , 21 (1) pp. 11-17.

J

Jagsi, R; Makris, A; Goldberg, S; Taghian, A; (2006) Intra-European differences in the radiotherapeutic management of breast cancer: A survey study. CLINICAL ONCOLOGY , 18 (5) pp. 369-375.

Jones, SF; Plummer, ER; Burris, HA; Razak, AR; Meluch, AA; Bowen, CJ; Williams, DH; ... Calvert, AH; + view all (2006) Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors. J Clin Oncol , 24 (18_suppl) 2027-.

Julia, LS; (2006) You Don't Have to Smoke to Get Lung Cancer. Sunday Telegraph, Stella Magazine

K

Kaufmann, M; Hortobagyi, GN; Goldhirsch, A; Scholl, S; Makris, A; Valagussa, P; Blohmer, JU; ... von Minckwitz, G; + view all (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update. JOURNAL OF CLINICAL ONCOLOGY , 24 (12) pp. 1940-1949.

Khoja, L; Mulyati, M; Lee, SM; (2006) Secondline chemotherapy in NSCLC. Lung Cancer in Practice , 3 (1) pp. 6-7.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shahbakhti, H; Robson, M; ... Chester, KA; + view all (2006) Clearance Mechanism Of A Mannosylated Antibody-Enzyme Fusion Protein Used In Experimental Cancer Therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

L

Ladenstein, R; Whelan, J; Oberlin, O; Weston, C; Jurgens, H; (2006) Multivariate analysis based risk grouping of Ewing tumours with extrapulmonary metastatic disease. Results from the EURO EWING 99 Study. In:

Lambros, MBK; Simpson, PT; Jones, C; Natrajan, R; Westbury, C; Steele, D; Savage, K; ... Reis-Filho, JS; + view all (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) pp. 398-408. 10.1038/labinvest.3700390.

Last, K; Maharaj, L; Perry, J; Strauss, S; Fitzgibbon, J; Lister, TA; Joel, S; (2006) The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours. Ann Oncol , 17 (5) 773-9-773-9.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; ... Hartley, JA; + view all (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. Bioorganic and Medicinal Chemistry Letters , 16 (24) pp. 1661-1664.

Leary, A.; (2006) Quality of life in patients receiving platinum based chemotherapy for advanced non-small cell lung cancer. Doctoral thesis , University of London. Green open access
file

Liobikas, J; Polianskyte, Z; Speer, O; Thompson, J; Alakoskela, J-M; Peitsaro, N; Franck, M; ... Eriksson, O; + view all (2006) Expression and purification of the mitochondrial serine protease LACTB as an N-terminal GST fusion protein in Escherichia coli. Protein Expression and Purification , 45 (2) pp. 335-342. 10.1016/j.pep.2005.08.006.

Lipton, L.R.; (2006) Familial colorectal cancer and polyposis genes, pathways and predictions. Doctoral thesis , University of London. Green open access
file

Louise, J; (2006) Thalidomide makes a comeback-but at what cost? Morning Star

M

Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; ... Joel, SP; + view all (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davics, N; Tibbals, J; ... Burroughs, A; + view all (2006) Transarterial therapy for hepatocellular carcinoma (HCC) in cirrhosis: Is embolization as effective as chemoembolization? Systematic review of cohort and randomized studies. In: (Proceedings) 41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver. (pp. S106-S106). ELSEVIER SCIENCE BV

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; ... Begent, RH; + view all (2006) A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research , 12 (21) pp. 6509-6516.

McTiernan, A; Whelan, J; Leahy, M; Woll, PJ; Judson, I; (2006) A phase II nonrandomised open-label study of liposomal daunorubicin (DaunoXome) in advanced soft tissue sarcoma. Sarcoma , 2006 10.1155/SARCOMA/41080. Gold open access

Mita, MM; Ochoa, L; Rowinsky, EK; Kuhn, J; Schwartz, G; Hammond, LA; Patnaik, A; ... Cunningham, D; + view all (2006) A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (GenasenseTM, G3139) and irinotecan in patients with metastatic colorectal cancer. Advances in Gastrointestinal Cancers , 4 (1) pp. 20-21.

N

Nair, SB; Pipinikas, C; Kirby, R; Carter, N; Fenske, C; (2006) Molecular diagnosis and staging of prostate cancer using clusterin in real time reverse transcription polymerase chain reaction (RT-PCR). In: (Proceedings) Annual Meeting of the American-Urological-Association. (pp. pp. 485-486). LIPPINCOTT WILLIAMS & WILKINS

Ng, QS; Goh, V; Fichte, H; Klotz, E; Fernie, P; Saunders, MI; Hoskin, PJ; (2006) Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements. RADIOLOGY , 239 (2) pp. 547-553.

Nicholls, J.; (2006) Investigating protein complexes that are involved in the function and regulation of the human INK4a/ARF locus. Doctoral thesis , University of London. Green open access

O

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: Differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) pp. 233-239. 10.1007/s00256-005-0006-z.

O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) pp. 345-350.

P

Pankhurst, T; Howie, AJ; Adu, D; Wallace, DMA; Lipkin, GW; (2006) Incidental neoplasms in renal biopsies. Nephrol Dial Transplant , 21 (1) pp. 64-69. 10.1093/ndt/gfi149.

Perisoglou, M; Seddon, B; Daniels, S; Mayne, N; Whelan, J; (2006) Incidence of delays in methotrexate toxicity in treatment of osteosarcoma. In:

Plummer, R; Lorigan, P; Evans, J; Steven, N; Middleton, M; Wilson, R; Snow, K; ... Calvert, H; + view all (2006) First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). J Clin Oncol , 24 (18_suppl) 8013-.

Plummer, R; Lorigan, P; Evans, J; Steven, N; Middleton, M; Wilson, R; Snow, K; ... Calvert, H; + view all (2006) First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AGO14699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 456S - 456S). AMER SOC CLINICAL ONCOLOGY

Plummer, R; Vidal, L; Li, L; Shaw, H; Perrett, R; Shahidi, M; Amelsberg, A; ... de Bono, J; + view all (2006) Phase I study of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, showing activity in tumours with mutated EGFR. EJC SUPPL , 4 (12) 173 - 174.

R

Rades, D; Stalpers, LJA; Schulte, R; Veninga, T; Basic, H; Engenhart-Cabilic, R; Schild, SE; (2006) Defining the appropriate radiotherapy regimen for metastatic spinal cord compression in non-small cell lung cancer patients. EUROPEAN JOURNAL OF CANCER , 42 (8) pp. 1052-1056.

Rades, D; Stalpers, LJA; Veninga, T; Hoskin, PJ; (2006) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) pp. 872-875.

Rades, D; Stalpers, LJA; Veninga, T; Rudat, V; Schulte, R; Hoskin, PJ; (2006) Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. The Journal of Urology , 175 (2) pp. 552-556.

Rades, D; Walz, J; Stalpers, LJA; Veninga, T; Schulte, R; Obralic, N; Wildfang, I; ... Schild, SE; + view all (2006) Short-course radiotherapy (RT) for metastatic spinal cord compression (MSCC) due to renal cell carcinoma: Results of a retrospective multi-center study. EUROPEAN UROLOGY , 49 (5) pp. 846-852.

Ranson, R; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; Halbert, G; ... Margison, GP; + view all (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA alkyltransferas: Phase 1 safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumours. Clinical Cancer Research , 12 (5) pp. 1577-1584.

Ravn, P; Patel, A; Andre, M; Bicknell, R; Begent, R; Pedley, B; Chester, K; (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

S

Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Saunders, MI; Rojas, A; (2006) Burning issues in CERT. In: (Proceedings) 3rd International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology. (pp. S19-S19). ELSEVIER IRELAND LTD

Shanley, S; McReynolds, K; Ardern, JA; Ahern, R; Fernando, I; Yarnold, J; Evans, G; ... Easton, DAER; + view all (2006) Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clinical Cancer Research , 1 (12) pp. 7025-7032.

Shanley, S; McReynolds, K; Ardern-Jones, A; Ahern, R; Fernando, I; Yarnold, J; Evans, G; ... Eeles, R; + view all (2006) Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clinical Cancer Research , 12 (23) pp. 7033-7038. 10.1158/1078-0432.CCR-06-1246.

Shaw, H; Plummer, R; Vidal, L; Perrett, R; Pilkington, M; Temple, G; Fong, P; ... De Bono, J; + view all (2006) A phase I dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in patients with advanced solid tumours. J Clin Oncol , 24 (18_suppl) 3027-.

Short, S; (2006) UNSPECIFIED In: (Proceedings) 3rd International Conference on Translational Research and Preclinical Strategies in Radiation Oncology.

Short, S; (2006) BBC 6 O'Clock news. UNSPECIFIED

Sizer, B; Makris, A; Barone, C; Mainwaring, P; Eggleton, P; (2006) QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. In: (pp. 178S-178S).

Soffietti, R; Cornu, P; Delattre, JY; Grant, R; Graus, F; Grisold, W; Heimans, J; ... Vecht, C; + view all (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. EUROPEAN JOURNAL OF NEUROLOGY , 13 (7) pp. 674-681.

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 533S - 533S). AMER SOC CLINICAL ONCOLOGY

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. J Clin Oncol , 24 (18_suppl) 9555-.

Stephens, R; Hoskin, P; (2006) Clinical trials and modern advertising: The Lung Cancer Trials Flowchart. ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Strauss, SJ; Maharaj, L; Hoare, S; Johnson, PW; Radford, JA; Vinnecombe, S; Millard, L; ... Lister, TA; + view all (2006) Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. J Clin Oncol , 24 (13) pp. 2105-2112. 10.1200/JCO.2005.04.6789.

Strauss, SJ; Morschhauser, F; Rech, J; Repp, R; Solal-Celigny, P; Zinzani, PL; Engert, A; ... Lister, TA; + view all (2006) Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin’s lymphoma. J Clin Oncol , 24 (24) pp. 3880-3886. 10.1200/JCO.2006.05.6291.

T

Thirlwell, C.; (2006) Mechanisms of colorectal tumorigenesis associated with Mut-Y (MYH) deficiency and identification of novel predisposition genes in the multiple adenoma phenotype. Doctoral thesis , University of London. Green open access
file

Thompson, J; Lepikhova, T; Teixido-Travesa, N; Whitehead, MA; Palvimo, JJ; Jänne, OA; (2006) Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. The EMBO Journal , 25 (12) pp. 2757-2767. 10.1038/sj.emboj.7601161.

Tolner, B; Hillyer, T; Smith, L; Begent, RHJ; Contreras, R; Chester, KA; (2006) A Recombinant Antibody-Enzyme Fusion Protein Produced in Pichia Pastoris in Compliance with EU Clinical Trials Directive for Phase I/II Cancer Trials. In: (Proceedings) NCRI Cancer Conference Proceedings.

Toumpanakis, C; Meyer, T; Standish, R; Beisnab, E; Buscombe, J; Caplin, ME; (2006) Goblet cell carcinoid tumours (Adenocarcinoid). In: (Proceedings) 3rd Annual Conference of the European-Neuroendocrine-Tumor-Society (ENETS). (pp. p. 50). KARGER

V

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2006) What is the optimum breast plan: a study based on the START trial plans. British Journal of Radiology , 79 (945) pp. 734-739.

W

Whelan, J; Bielack, S; Marina, N; Smeland, S; Bernstein, M; (2006) . EURAMOS 1 - international randomised trial in a rare cancer: last of a soon-to-be extinct species or hope for the future? In:

Whelan, J; Dolbear, C; Davies, E; Moller, H; (2006) Where do teenagers and young adults receive treatment for cancer? In:

Whelan, J; McTiernan, A; Weston, C; Douglas, C; Grimer, R; Cassoni, A; Paulussen, M; ... Lewis, I; + view all (2006) Consequences of different approaches to local treatment of Ewing's sarcoma within an international randomised controlled trial: Analysis of EICESS-92. In: (pp. 528S-528S).

Whelan, JS; Cassoni, AM; Pollock, R; (2006) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS; McTiernan, A; Weston, C; Douglas, C; Grimer, R; Cassoni, A; Spooner, D; ... Lewis, I; + view all (2006) Consequences of different approaches to local treatment of Ewing’s sarcoma within an international randomised controlled trial: analysis of EICESS-92. In:

Whelan, JS; Seddon, BM; Perisoglou, M; (2006) Current Management of Osteosarcoma. Current Treatment Options in Oncology , 7 pp. 444-455.

Wilson, GD; Saunders, MI; Dische, S; Daley, FM; Buffa, FM; Richman, PI; Bentzen, SM; (2006) Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy. EUROPEAN JOURNAL OF CANCER , 42 (3) pp. 363-371.

This list was generated on Sun Apr 15 01:55:11 2018 BST.